SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 2.57
52-Week Change 3-36.92%
S&P500 52-Week Change 313.25%
52 Week High 314.65
52 Week Low 36.22
50-Day Moving Average 38.03
200-Day Moving Average 38.15

Share Statistics

Avg Vol (3 month) 3763.49k
Avg Vol (10 day) 3854.9k
Shares Outstanding 5112.97M
Float 109.62M
% Held by Insiders 110.19%
% Held by Institutions 180.12%
Shares Short (Oct 31, 2019) 48.45M
Short Ratio (Oct 31, 2019) 413.38
Short % of Float (Oct 31, 2019) 49.00%
Short % of Shares Outstanding (Oct 31, 2019) 47.48%
Shares Short (prior month Sep 30, 2019) 48.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 28, 2012
Ex-Dividend Date 4Dec 18, 2012
Last Split Factor (new per old) 225/1
Last Split Date 3Sep 6, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin -112.28%
Operating Margin (ttm)-128.35%

Management Effectiveness

Return on Assets (ttm)-24.83%
Return on Equity (ttm)-54.35%

Income Statement

Revenue (ttm)109.33M
Revenue Per Share (ttm)1.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)82.58M
EBITDA -111.88M
Net Income Avi to Common (ttm)-141.72M
Diluted EPS (ttm)-1.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)247.76M
Total Cash Per Share (mrq)2.23
Total Debt (mrq)3.75M
Total Debt/Equity (mrq)1.60
Current Ratio (mrq)5.71
Book Value Per Share (mrq)2.11

Cash Flow Statement

Operating Cash Flow (ttm)-115.75M
Levered Free Cash Flow (ttm)-44.06M